Perrigo Company plc Ordinary Shares (PRGO): Price and Financial Metrics
Perrigo Company plc Ordinary Shares (PRGO)
Today's Latest Price: $43.71 USD
Updated Jan 15 7:00pm
Add PRGO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
PRGO Stock Summary
- With a one year PEG ratio of 1,297.86, PERRIGO Co plc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 96.94% of US stocks.
- PERRIGO Co plc's stock had its IPO on December 17, 1991, making it an older stock than 82.18% of US equities in our set.
- The volatility of PERRIGO Co plc's share price is greater than that of just 12.8% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to PERRIGO Co plc are MTLS, QBAK, PEN, THR, and CUB.
- Visit PRGO's SEC page to see the company's official filings. To visit the company's web site, go to www.perrigo.com.
PRGO Stock Price Chart Interactive Chart >
PRGO Price/Volume Stats
| Current price | $43.71 | 52-week high | $63.86 |
| Prev. close | $44.65 | 52-week low | $40.01 |
| Day low | $43.50 | Volume | 2,426,200 |
| Day high | $45.20 | Avg. volume | 1,452,750 |
| 50-day MA | $46.59 | Dividend yield | 2.06% |
| 200-day MA | $50.20 | Market Cap | 5.97B |
Perrigo Company plc Ordinary Shares (PRGO) Company Bio
Perrigo Company develops, manufactures, and distributes generic prescription pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients and pharmaceutical and medical diagnostic products. The company was founded in 1887 and is based in Dublin, Ireland.
PRGO Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $43.71 | $11 | -75% |
Below please find a table outlining a discounted cash flow forecast for PRGO, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that PERRIGO Co plc ranked in the 21th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for PRGO, they are:
- The company's balance sheet shows it gets 63% of its capital from equity, and 37% of its capital from debt. Its equity weight surpasses that of only 16.2% of free cash flow generating stocks in the Healthcare sector.
- Its compound free cash flow growth rate, as measured over the past 5.53 years, is -0.11% -- higher than just 12.84% of stocks in our DCF forecasting set.
- PERRIGO Co plc's weighted average cost of capital (WACC) is 10%; for context, that number is higher than 70.32% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -76% |
| 1% | -76% |
| 2% | -75% |
| 3% | -75% |
| 4% | -75% |
| 5% | -75% |
Want more companies with a valuation profile/forecast similar to that of PERRIGO Co plc? See BSX, EHC, MTD, NUVA, and CNC.
Loading social stream, please wait...